Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print November 14, 2007
DOI: 10.2337/db07-1204

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-1204v1
57/4/879    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shanmugam, N.
Right arrow Articles by Natarajan, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shanmugam, N.
Right arrow Articles by Natarajan, R.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Pro-inflammatory Effects of Advanced Lipoxidation End Products in Monocytes.

Narkunarajaa Shanmugam, Ph.D1, James L Figarola, Ph.D1, Yan Li, BS1, Piotr M. Swiderski, Ph.D, Samual Rahbar, PhD, MD, and Rama Natarajan, Ph.D1

1 Department of Diabetes
DNA RNA & Peptide Synthesis Lab, Beckman Research Institute of City of Hope, 1500 East Duarte Road, Duarte, CA 91010

Background: The reactions of carbohydrate or lipid derived intermediates with proteins lead to the formation of Maillard reaction products, which subsequently lead to the formation of advanced glycation/lipoxidation end products (AGE/ALEs). Levels of AGE/ALEs are increased in diseases like diabetes. Unlike AGEs, very little is known about ALE effects in vitro. We hypothesized that ALEs can have pro-inflammatory effects in monocytes.

Methods and Results: Synthetic ALE (malondialdehyde-lysine, MDA-Lys) (50µmol/l) could induce oxidant stress and also activate the transcriptional factor NF-{kappa}B in THP-1 monocytes. MDA-Lys also significantly increased the expression of key candidate pro-inflammatory genes, Interferon-{gamma}-inducible protein-10, ß1 and ß2-Integrins, cyclooxygenase-2, monocyte chemoattractant protein-1 (MCP-1), interleukins-6 and-8, and iNOS that are also associated with monocyte dysfunction. In a profiling approach, conditioned media from THP-1 cells cultured either in normal glucose (NG, 5.5 mM) or treated with MDA-Lys or MDA alone were hybridized to arrays containing antibodies to 120 known human cytokines/chemokines. Several key target pro-inflammatory proteins were significantly induced by MDA-Lys relative to NG or MDA alone, including MCP-1, TNF ligand superfamily member-14, Chemokine CC motif Ligand-11 (CCL-11), Growth Related Oncogene {alpha}, ß, {gamma}, and Chemokine CXC motif Ligand-13. Pathway analyses with bioinformatics software identified a network of chemokine signaling amongst MDA-Lys regulated genes. MDA-Lys also increased monocyte binding to vascular smooth muscle and endothelial cells. Furthermore, plasma from diabetic rats showed significantly higher levels of MDA-Lys as well as CCL11.

Conclusion: These new results suggest that ALEs can promote monocyte activation and vascular complications via induction of inflammatory pathways and networks.


Correspondence: rnatarajan{at}coh.org


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.